WebNews
Please enter a web search for web results.
NewsWeb
RVO risk factors and systemic outcomes
15+ hour ago (46+ words) Katherine Talcott, MD of the Cole Eye Institute joins Modern Retina to discuss how RVO risk factors like hypertension, hyperlipidemia, and diabetes can predict serious downstream systemic outcomes'and why retina specialists must ensure these patients are connected to comprehensive cardiovascular…...
Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, Ph D
17+ hour, 55+ min ago (213+ words) Modern Retina For Jay S. Duker, MD, and Ramiro Ribeiro, MD, Ph D, paths that began in clinical and academic medicine became the foundation for a different kind of work'leading drug development from the inside. In this episode, Eichenbaum speaks with…...
Altered ip RGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer's disease
2+ day, 11+ hour ago (500+ words) Modern Retina He is from Fribourg Cantonal Hospital, Neurology Department, Fribourg, Switzerland, and the Department of Clinical Neurosciences, Geneva University, Geneva, Switzerland Sanda and colleagues explained, "One of the earliest symptoms in Alzheimer's disease is a disruption of sleep and…...
Stem Sight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3+ day, 6+ hour ago (677+ words) Modern Retina...
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD'what the SOL-1 data mean for retina practice
3+ day, 20+ hour ago (491+ words) Modern Retina Mark Barakat, MD, vitreoretinal surgeon and director of research at the Retina Macula Institute of Arizona, spoke with Modern Retina following the 2026 Clinical Trials at the Summit (CTS), held June 1213 at the Fontainebleau Hotel in Las Vegas, Nevada…...
Ranluspec FDA approval: Cyrus Karkaria, Ph D, on biosimilar access, prefilled syringes, and long-term switching confidence
4+ day, 6+ hour ago (349+ words) Learn how FDA's interchangeable ranibizumab biosimilar may streamline injections, cut costs, and guide safe switching for retina patients. In the following Q&A, Karkaria discusses the efficiency and safety advantages of the prefilled syringe format in high-volume intravitreal injection settings,…...
Geographic atrophy: When lesion borders cannot be graded
6+ day, 17+ hour ago (111+ words) Modern Retina Among the 7 ungradable eyes on UWF GAF, 6 showed sharp demarcation of atrophy borders on companion UWF pseudocolor imaging and were deemed gradable for lesion size. The authors note that this reduces the overall proportion of eyes not amenable…...
The Trials Reshaping Retina Care With Arshad M. Khanani, MD, MA, FASRS
1+ week, 2+ hour ago (88+ words) Wet AMD, TKIs & Gene Therapy: The Trials Reshaping Retina Care Arshad M. Khanani, MD, MA, FASRS, founder and cochair of Clinical Trials at the Summit 2026, previews what attendees can expect at the meeting, set for June 1213 in Las Vegas, Nevada. The…...
The Residency Report: Finding Undiagnosed Glaucoma in the Community
1+ week, 1+ day ago (95+ words) In this episode of The Residency Report, Anne Coleman, MD, Ph D, Chair in Ophthalmology at the Jules Stein Eye Institute, UCLA, explains why she chose to spotlight her research on the Pooled Cohort Equations and Ocular Disease Index, and…...
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
1+ week, 3+ day ago (91+ words) Modern Retina Meeting founder and co-chair Arshad M. Khanani, MD, MA, FASRS, shares what attendees can expect during this year's program, opening the evening of June 12 and running through June 13 in Las Vegas, Nevada. "It's all stakeholders together trying to go…...